ILX651 administered daily for five days every 3 weeks (qdx5dq3w) in patients (pts) with inoperable locally advanced or metastatic melanoma: Phase II experience No significant financial relationships ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results